The Future of Asian Family Businesses – Asrar Qureshi’s Blog Post #1301

This blog post by Asrar Qureshi discusses the challenges and opportunities facing Asian family businesses as they transition to professional enterprises. Key issues include the changing dynamics of succession, the need for professionalization, and the importance of adaptability in light of technological and geopolitical shifts. Successful family businesses will balance family values with business needs for long-term relevance.
Share
View Post
  • 6 min

Requirements to Reach Pharma C-Suite – Asrar Qureshi’s Blog Post #1300

Asrar Qureshi’s 1300th blog post for Pharma Veterans emphasizes that reaching the C-suite requires more than technical expertise in one area. Aspiring executives must develop cross-functional fluency, build exceptional leaders, and maintain organizational alignment. Success hinges on experience, judgment, and the ability to simplify complex issues for diverse stakeholders.
Share
View Post
  • 6 min

Funding Cuts Threaten Progress Against HIV, Hepatitis and STIs – Asrar Qureshi’s Blog Post #1298

The WHO warns that declining international funding threatens progress against HIV, hepatitis, and STIs. After decades of advancements, reduced financial support risks reversing achievements in prevention, testing, and treatment. Sustained investment, community leadership, and integrated healthcare are crucial to maintaining progress and addressing global health equity.
Share
View Post
  • 6 min

Malnutrition in Children Crisis – Asrar Qureshi’s Blog Post #1297

The blog post highlights a critical rise in child malnutrition in Quetta, Pakistan, as reported by Action Against Hunger. With 29.1% of children under five facing Global Acute Malnutrition, urgent action is needed. The issue stems from interconnected causes like inadequate diets and poor healthcare, with long-term impacts on children’s development and national progress.
Share
View Post
  • 6 min

AI and the Risk of Losing Human Skills – Suggestion to Tackle – Asrar Qureshi’s Blog Post #1296

Asrar Qureshi’s blog discusses the importance of balancing AI adoption with human intelligence, emphasizing that while AI enhances productivity, it should not replace critical thinking and creativity. Organizations must design workflows thoughtfully, ensuring that human accountability and learning opportunities remain prioritized, particularly in sectors like pharmaceuticals and education.
Share
View Post
  • 6 min

AI and the Risk of Losing Human Skills – Asrar Qureshi’s Blog Post #1295

Asrar Qureshi’s blog discusses the transformative impact of AI on productivity and the potential risks of cognitive decline within organizations. The concept of “cognitive debt” suggests that over-dependence on AI may weaken essential human skills like judgment and creative thinking. Leaders must foster deep thinking to safeguard these capabilities while leveraging AI’s advantages.
Share
View Post
  • 6 min

7 Deadly Mistakes New Small Businesses Must Avoid – Asrar Qureshi’s Blog Post #1294

Asrar Qureshi’s blog post explores seven critical mistakes that can lead to small business failures and offers insights on how entrepreneurs can avoid them. Key points include understanding customer needs, developing reliable customer acquisition strategies, protecting cash flow, and building efficient systems. Successful businesses are built on sound decision-making and adaptability.
Share
View Post
  • 6 min

The Exit of Multinational Pharmaceutical Companies from Pakistan – Part 3 – Asrar Qureshi’s Blog Post #1293

Asrar Qureshi’s blog discusses the exit of multinational pharmaceutical companies from Pakistan and the country’s potential to attract them back. Highlighting necessary reforms in pricing, regulation, and clinical research, it stresses a long-term vision for the pharmaceutical sector as vital for economic growth and public health security. Collaboration between domestic and multinational firms is essential for success.
Share
View Post
  • 6 min

The Exit of Multinational Pharmaceutical Companies from Pakistan – Part 2 – Asrar Qureshi’s Blog Post #1292

This blog post by Asrar Qureshi examines the exit of multinational pharmaceutical companies from Pakistan, analyzing its historical context and impacts on the healthcare system. While local firms maintain medicine availability, concerns arise regarding innovation and clinical research. The challenge remains to balance local manufacturing capabilities with the need for multinational investment and research.
Share